GlassScriptPhysician profile
Briana Britton
NPI 1306404793
$2,362.12
in general payments reported to CMS, 2019-2025
8 companies · $1,797 in 2025
The $1,797 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $12.41 · 2023: $252 · 2024: $301 · 2025: $1,797.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $1,294 · Food and Beverage: $1,056.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $1,293.86 |
| Food and Beverage | $1,055.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,551.97 | 2025 | Micromatrix, Integra, Integra Dermal Regeneration Template |
| Medtronic, INC. | $252.16 | 2023 | Signia |
| Stryker Corporation | $137.74 | 2024 | Spy-Phi System |
| Ethicon US, LLC | $131.99 | 2024 | Surgicel Nu-Knit |
| Abiomed | $130.20 | 2025 | |
| Solventum Corporation | $114.66 | 2025 | V.A.C.Instill, Prevena, Abthera |
| Baxter Healthcare | $30.99 | 2024 | |
| Boston Scientific Corporation | $12.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Briana Britton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.